New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-κB and AP-1 activation

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7102-7109

  Mortellaro, Alessandra ^a   Songia, Simona ^a   Gnocchi, Paola ^b   Ferrari, Mario ^b   Fornasiero, Chiara ^b   D'Alessio, Roberto ^b   Isetta, Anna ^b   Colotta, Francesco ^b   Golay, Josée ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYCLINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; MESSENGER RNA; PRODIGIOSIN; PROTEIN BCL 2; RAPAMYCIN; TACROLIMUS;

ARTICLE; CELL ACTIVATION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA; T LYMPHOCYTE;

EID: 0033564946     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Calne, R. Y., S. Thiru, P. McMaster, G. N. Craddock, D. J. G. White, D. B. Evans, D. C. Dunn, and B. D. Pentlow. 1978. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2:1323.
2. Canadian Multicenter Transplant Study Group. 1986. A randomized clinical trial of cyclosporin in cadaveric renal transplantation. N. Engl. J. Med. 314:1219.
3. Sigal, N. H., and F. J. Dumont. 1992. Cyclosporin A, FK-506, and rapamycin: pharmacological probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:519.
4. Thomson, A. W., and T. E. Starzl. 1993. New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol. Rev. 136:72.
5. Songia, S., A. Mortellaro, S. Taverna, C. Fornasiero, E. Scheiber, E. Erba, F. Colotta, A. Mantovani, A. M. Isetta, and J. Golay. 1997. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets. J. Immunol. 158:3987.
6. Golay, J., G. Cusmano, and M. Introna. 1992. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J. Immunol. 149:300.
7. - B lymphocytes and in Burkitt's lymphoma cell lines. J. Immunol. 153:543.
8. Theze, J., P. M. Alzari, and J. Bertoglio. 1996. Interleukin 2 and its receptor: recent advances and new immunological functions. Immunol. Today 17:481.
9. Rebollo, A., J. Gomez, and C. Martinez-A. 1996. Lessons from immunological, biochemical and molecular pathways of the activation mediated by IL-2 and IL-4. Adv. Immunol. 63:127.
10. Beadling, C., J. Babbage, and D. A. Cantrell. 1994. Activation of Jak kinases and STAT proteins by Interleukin-2 and interferon-α, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13:5605.
11. O'Shea, J. J. 1997. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7:1.
12. Takeshita, T., T. Arita, M. Higuchi, H. Asao, K. Endo, H. Kuroda, N. Tanaka, K. Murata, N. Ishii, and K. Sugamura. 1997. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity 6:449.
13. Pastor, M. I., K. Reif, and D. Cantrell. 1995. The regulation and function of p21ras during T cell activation and growth. Immunol. Today 16:159.
14. Robinson, M. J., and M. H. Cobb. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:180.
15. May, M. J., and S. Ghosh. 198. Signal transduction through NF-κB. Immunol. Today 19:80.
16. Maniatis, T. 1997. Catalysis by a multiprotein IκB kinase complex. Science 278:818.
17. Tsuji, R. F., M. Yamamoto, A. Nakamura, T. Kataoka, J. Magae, K. Nagai, and M. Yamasaki. 1990. Selective immunosuppression of Prodigiosin 25-C and FK506 in the murine immune system. J. Antibiot. (Tokyo) 43:1293.
18. Tsuji, R. F., J. Magae, M. Yamashita, K. Nagai, and M. Yamasaki. 1992. Immunomodulating properties of Prodigiosin 25-C, an antibiotic which preferentially suppresses induction of cytotoxic T cells. J. Antibiot. (Tokyo) 45:1295.
19. Abraham, R. T., and G. J. Wiederrecht. 1996. Immunopharmacology of Rapamycin. Annu. Rev. Immunol. 14:483.
20. Brazelton, T. R., and R. E. Morris. 1996. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Curr. Opin. Immunol. 8:710.
21. Calvo, V., C. M. Crews, T. A. Vik, and B. E. Bierer. 1992. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc. Natl. Acad. Sci. USA 89:7571.
22. Brennan, P., J. W. Babbage, B. M. T. Burgering, B. Groner, K. Reif, and D. Cantrell. 1997. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679.
23. Lee, F. S., J. Hagler, Z. J. Chen, and T. Maniatis. 1997. Activation of the IκB-α kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88:213.
24. 1 phase progression: cycling on cue. Cell 79:551.
25. 1 phase in primary human T lymphocytes. J. Biol. Chem. 268:4113.
26. Furukawa, Y., J. A. DeCaprio, A. Freedman, Y. Kanakura, M. Nakamura, T. J. Ernst, D. M. Livingston, and J. D. Griffin. 1990. Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human haematopoietic cells. Proc. Natl. Acad. Sci. USA 87:2770.
27. Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. H. Lee, J. Massague, G. R. Crabtree, and J. M. Roberts. 1994. Interieukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570.
28. Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell Biol. 14:4889.
29. Miyazaki, T., Z. J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E. L. Barsoumian, R. M. Perlmutter, and T. Taniguchi. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc and lck cooperate in hematopoietic cell proliferation. Cell 81:223.
30. Minami, Y., Y. Nakagawa, A. Kawahara, T. Miyazaki, K. Sada, H. Yamamura, and T. Taniguchi. 1995. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link in the c-myc induction pathway. Immunity 2:89.
31. Turner, B., U. Rapp, H. App, M. Greene, K. Dobashi, and J. Reid. 1991. Interleukin-2 induces tyrosine phosphorylation and activation of p72-74 Raf-1 kinase in a T cell line. Proc. Natl. Acad. Sci. USA 88:1227.
32. Witthuhn, B., O. Silvennoinen, O. Miura, K. Lai, C. Cwik, E. Liu, and J. Ihle. 1994. Involvement of the Jak-3 Janus kinase in signalling by interleukin 2 and 4 in lymphoid and myeloid cells. Nature 370:153.
33. Johnston, J., M. Kawamura, R. Kirken, Y. Chen, T. Blake, K. Shibuya, J. Ortaldo, D. McVicar, and J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151.
34. Reif, K., B. M. T. Burgering, and D. A. Cantrell. 1997. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 272:14426.
35. Karnitz, L. M., L. A. Burns, S. L. Sutor, J. Blenis, and R. T. Abraham. 1995. Interleukin-2 triggers a novel phosphatidyl 3-kinase-dependent MEK activation pathway. Mol. Cell Biol. 15:3049.
36. Taniguchi, T. 1995. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251.
37. Ahmed, N. N., H. L. Grimes, A. Bellacosa, T. O. Chan, and P. N. Tsichlis. 1997. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA 94:3627.
38. Jacinto, E., G. Werlen, and M. Karin. 1998 Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes. Immunity 8:41.
39. Fujii, H., Y. Nakagawa, U. Schindler, A. Kawahara, H. Mori, F. Gouilleux, B. Groner, J. N. Ihle, Y. Minami, T. Miyazaki, and T. Taniguchi. 1995. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor chain but is not essential for the proliferative signal transmission. Proc. Natl Acad. Sci. USA 92:5482.
40. Arima, N., W. A. Kuziel, T. A. Grdina, and W. C. Greene. 1992. IL-2-induced signal transduction involves the activation of nuclear NF-κB expression. J. Immunol. 148:83.
41. Fairhurst, R. M., M. Daeipour, M. C. Amaral, and A. E. Nel. 1993. Activation of mitogen-activated protein kinase/ERK-2 in phytohaemagglutinin in blasts by recombinant interleukin-2: contrasting features with CD3 activation. Immunology 79:112.
42. Zamorano, J., H. Y. Wang, R. Wang, Y. Shi, G. D. Longmore, and A. D. Keegan, 1998. Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J. Immunol. 160:3502.
43. Crawley, J. B., L. Rawlinson, F. V. Lali, T. H. Page, J. Saklatvala, and B. M. J. Foxwell. 1997. T cell proliferation in response to Interleukin 2 and 7 requires p38 MAP kinase activation. J. Biol. Chem. 272:15023.
44. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed. Cell 91:299.
45. Wang, W., W. F. Tam, C. C. W. Hughes, S. Rath, and R. Sen. 1997. C-rel is a target of pentoxiffylline-mediated inhibition of T lymphocyte activation. Immunity 6:165.
46. Mercurio, F., H. Zhu, and B. W. Murray. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860.
47. Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90:373.
48. Koretzky, G. A. 1997. The role of Grb2-associated proteins in T cell activation. Immunol. Today 18:401.
49. Karin, M., Z. G. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240.
50. Ravichandran, K. S., S. J. Burakoff. 1994. The adaptor protein She interacts with the Interleukin-2 (IL-2) receptor upon IL-2 stimulation. J. Biol. Chem. 269:1599.
51. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13.